Literature DB >> 15956503

Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results.

Dong Joon Kim1, Byung Hee Lee, Dong Ik Kim, Won Heum Shim, Pyoung Jeon, Tae Hong Lee.   

Abstract

BACKGROUND AND
PURPOSE: The natural history of symptomatic, untreated posterior circulation stenosis is dismal, with many patients experiencing significant morbidity or mortality. The purpose of this study was to evaluate the feasibility and results of stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis.
METHODS: We reviewed the imaging findings and medical records of 17 consecutive patients who were treated with stent-assisted angioplasty for medically refractory vertebrobasilar artery stenosis. The location of the lesion, degree of stenosis, procedure-related complications, and clinical and short- and long-term angiographic results were assessed.
RESULTS: The population included 17 cases (10 men, seven women; age range, 51-74 years; mean, 64 years). The locations of the lesions were intracranial vertebral artery (n = 13) and basilar artery (n = 6). The mean degree of stenosis decreased from 76.1 +/- 14.6% before stent-assisted angioplasty to 1.3 +/- 2.8% (P < .05) after the procedure. Acute in-stent thrombosis developed in one case (6%, Mori type B lesion), which was successfully treated with intraarterial abciximab infusion and angioplasty. Another patient (6%, Mori type C lesion) developed immediate postprocedural transient diplopia and ataxia, which gradually resolved. No other patient showed symptoms related to the vertebrobasilar artery lesion at follow-up. No significant restenosis was observed at short-term (five patients; follow-up range, 0.5-6 months; mean, 4.3 months) or long-term (six patients; follow-up range, 12-41 months; mean, 21 months) angiographic follow-up.
CONCLUSION: Stent-assisted angioplasty is a feasible treatment method for vertebrobasilar artery stenosis. The patency of the stent-assisted angioplasty seems to be preserved in the long-term, with good clinical outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15956503      PMCID: PMC8149083     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  35 in total

Review 1.  Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: three technical case reports and literature review.

Authors:  M B Horowitz; G L Pride; D F Graybeal; P D Purdy
Journal:  Neurosurgery       Date:  1999-10       Impact factor: 4.654

2.  Intracranial deployment of coronary stents for symptomatic atherosclerotic disease.

Authors:  P P Morris; E M Martin; J Regan; G Braden
Journal:  AJNR Am J Neuroradiol       Date:  1999-10       Impact factor: 3.825

3.  Primary basilar artery stenting: immediate and long-term results in one patient.

Authors:  M Piotin; R Blanc; R Kothimbakam; D Martin; I B Ross; J Moret
Journal:  AJR Am J Roentgenol       Date:  2000-11       Impact factor: 3.959

Review 4.  ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology.

Authors:  D R Holmes; J Hirshfeld; D Faxon; R E Vlietstra; A Jacobs; S B King
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

5.  Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.

Authors:  O-Ki Kwon; Ki Jae Lee; Moon Hee Han; Chang-Wan Oh; Dae Hee Han; Young Cho Koh
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

6.  Elective stenting of symptomatic basilar artery stenosis.

Authors:  C R Gomez; V K Misra; M W Liu; V R Wadlington; J B Terry; R Tulyapronchote; M S Campbell
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

7.  Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis.

Authors:  T Mori; K Kazita; K Mori
Journal:  AJNR Am J Neuroradiol       Date:  1999-05       Impact factor: 3.825

8.  Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience.

Authors:  P A Rasmussen; J Perl; J D Barr; G Z Markarian; I Katzan; C Sila; D Krieger; A J Furlan; T J Masaryk
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

9.  Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty.

Authors:  T Mori; M Fukuoka; K Kazita; K Mori
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

10.  Intraarterial administration of Abciximab for thromboembolic events occurring during aneurysm coil placement.

Authors:  Charbel Mounayer; Michel Piotin; Sebastian Baldi; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

View more
  23 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

Review 2.  [Endovascular treatment for intracranial stenoses. A common statement by neurologists and neuroradiologists].

Authors:  J Berkefeld; G F Hamann; R du Mesnil; W Kurre; H Steinmetz; F E Zanella; M Sitzer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

Review 3.  Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.

Authors:  Colin P Derdeyn; Marc I Chimowitz
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

4.  Treatment of symptomatic complex posterior circulation cerebral artery stenosis with balloon-mounted stents: technique feasibility and outcome.

Authors:  Bin Wang; Zhong-rong Miao; Gui-lin Li; Yang Hua; Xun-min Ji; Li-qun Jiao; Ren-zhi Wang; Feng Ling
Journal:  Neuroradiology       Date:  2009-02-15       Impact factor: 2.804

5.  Cost-effectiveness analysis of intracranial stent placement versus contemporary medical management in patients with symptomatic intracranial artery stenosis.

Authors:  Amir Khan; Ameer Hassan; Fareed Suri; Adnan Qureshi
Journal:  J Vasc Interv Neurol       Date:  2013-12

6.  Angioplasty and stenting of symptomatic vertebral artery stenosis. Clinical and angiographic follow-up of 206 cases from Northwest Iran.

Authors:  R Mohammadian; E Sharifipour; R Mansourizadeh; B Sohrabi; A R Nayebi; S Haririan; M Farhoudi; S Charsouei; S Najmi
Journal:  Neuroradiol J       Date:  2013-08-27

Review 7.  Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives.

Authors:  Nestor R Gonzalez; David S Liebeskind; Joshua R Dusick; Fernando Mayor; Jeffrey Saver
Journal:  Neurosurg Rev       Date:  2012-10-25       Impact factor: 3.042

8.  Risk factors associated with major cerebrovascular complications after intracranial stenting.

Authors:  F Nahab; M J Lynn; S E Kasner; M J Alexander; R Klucznik; O O Zaidat; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M I Chimowitz
Journal:  Neurology       Date:  2009-03-18       Impact factor: 9.910

9.  Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results.

Authors:  W-J Jiang; X-T Xu; M Jin; B Du; K-H Dong; J-P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

10.  The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.

Authors:  O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.